Net Income

Aerospace innovator Helio Corp. appoints finance expert Edward Cabrera as CEO, signaling a major shift toward shareholder value and financial restructuring.

At CES 2026, Xthings redefines entry with new ULTRALOQ locks using facial recognition, palm veins, and UWB to make access truly invisible.

While US sales numbers declined in 2025, Mazda posted record CPO figures, earned top safety honors, and saw major growth in Canada and Mexico.

The fresh food packaging market is set to soar, but can it balance consumer demands for sustainability, safety, and convenience with the high costs of innovation?

Cosmos Health's subsidiary will manufacture the advanced generic pain reliever PathMuscle, securing a major contract and enhancing its European footprint.

With 4.68+ star ratings across all platforms, this online school is challenging competitors to stop hiding reviews and embrace total transparency.

With quantum threats looming, BTQ Technologies adds a Wall Street veteran to its board, signaling a strategic move to build credibility with financial institutions.

Processa Pharmaceuticals completes enrollment for a pivotal analysis of its NGC-Cap therapy, offering new hope for a safer, more effective cancer treatment.

Fewer than 10% of hospitals achieve Magnet status. City of Hope just earned it twice. Discover what this rare honor means for patient safety and nursing.

Following a period of mixed financials, Neogen appoints new leaders to drive innovation and growth in its critical global food safety division.

Selena Gomez's viral beauty brand lands in all Ulta stores, pioneering a new charitable model and intensifying the rivalry in prestige beauty retail.

With Talya Nevo-Hacohen retiring, veteran Darrin Smith takes the helm as CIO. How will his vision shape Sabra's portfolio in a dynamic healthcare REIT market?

Lucid crushed its 2025 production goals with a huge Q4 surge, but a widening gap between cars built and sold raises serious questions about demand.

A new initiative is tackling the fear and distrust that costs patients their health and the system trillions. Is 'cognitive safety' healthcare's next frontier?

Fintech firm Movemint's rebrand signals a major shift for banks, focusing on embedded finance and personalized experiences to drive measurable growth.

With a hot obesity pipeline and a key neurology asset, Nxera Pharma's J.P. Morgan talk is a crucial test of its plan for global leadership.

With surging revenue for its cholesterol drugs and new guideline backing, Esperion outlines its strategy for profitability and pipeline expansion.

AUKEY unveils a 200W GaN charging hub with retractable cables and 25W Qi2, leading a new lineup designed to declutter the modern professional's desk.

With stunning clinical data for its miv-cel therapy, Kyverna is set to outline a new era for autoimmune treatment at the J.P. Morgan conference.

With 35 years at the company, new CEO John Baylouny plans to accelerate R&D and expand into new markets, building on a period of strong growth.